Previous close | 0.0141 |
Open | 1.3700 |
Bid | 1.2300 x 1000 |
Ask | 1.4000 x 1100 |
Day's range | 0.0200 - 0.0290 |
52-week range | 0.0200 - 4.7430 |
Volume | |
Avg. volume | 6,563 |
Market cap | 769,747 |
Beta (5Y monthly) | 0.04 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.5760 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK, May 13, 2022--PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO.
NEW YORK, May 12, 2022--PAVmed provides business update and preliminary first quarter 2022 financial results.
NEW YORK, May 11, 2022--Lucid Diagnostics provides business update and preliminary first quarter 2022 financial results.